On February 18, 2025, Esperto Medical™, a healthtech start-up specializing in critical care and remote patient monitoring, announced the closing of an oversubscribed Series A investment round co-led by Catalyst Health Ventures and Bold Capital Partners, with support from Wavemaker Three-sixty Health, Free Flow Ventures, Fund@Caltech, and Maverick Ventures. Wilson Sonsini Goodrich & Rosati advised Esperto on the transaction.

The funding will facilitate the product development and clinical testing of Esperto's new Resonance Sonomanometry™ (RSM) technology.  RSM uses sound waves at different frequencies to directly measure blood pressure within arteries, avoiding the variability of other approaches, and requires no calibration.  The technology aims to improve cardiovascular monitoring for a wide range of patients. 

The Wilson Sonsini team that advised Esperto on the transaction includes:

Corporate 
Marty Waters
Tim Conroy
Trevor Dorne

Patents and Innovations
Ali Alemozafar

Technology Transactions
Nellie Brutocao
Isaiah Loya 

Employee and Benefits Compensation
Gregory Hughes 

Corporate - Delaware
Ryan Greecher 
James Griffin-Stanco 

For more information, please see Esperto's news release.